GO:0004832 | valine-tRNA ligase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0044212 | transcription regulatory region DNA binding | 1.80e-03 | 1.00e+00 | 3.591 | 3 | 13 | 143 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.85e-03 | 1.00e+00 | 2.858 | 4 | 17 | 317 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0042826 | histone deacetylase binding | 4.45e-03 | 1.00e+00 | 4.308 | 2 | 5 | 58 |
GO:0005515 | protein binding | 4.45e-03 | 1.00e+00 | 0.857 | 13 | 198 | 4124 |
GO:0006281 | DNA repair | 4.85e-03 | 1.00e+00 | 3.086 | 3 | 24 | 203 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 2 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0045292 | mRNA cis splicing, via spliceosome | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 2 | 4 |
GO:0071156 | regulation of cell cycle arrest | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 2 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0003723 | RNA binding | 8.36e-03 | 1.00e+00 | 2.803 | 3 | 22 | 247 |
GO:0090344 | negative regulation of cell aging | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0008080 | N-acetyltransferase activity | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 2 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0031681 | G-protein beta-subunit binding | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 3 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 4 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:0005730 | nucleolus | 1.35e-02 | 1.00e+00 | 1.502 | 6 | 74 | 1217 |
GO:0005845 | mRNA cap binding complex | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0006878 | cellular copper ion homeostasis | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 4 | 8 |
GO:0005654 | nucleoplasm | 1.43e-02 | 1.00e+00 | 1.713 | 5 | 68 | 876 |
GO:0010225 | response to UV-C | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0032039 | integrator complex | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 9 |
GO:0007049 | cell cycle | 1.67e-02 | 1.00e+00 | 3.320 | 2 | 8 | 115 |
GO:0001967 | suckling behavior | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 10 |
GO:0071564 | npBAF complex | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 3 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 4 | 11 |
GO:0008334 | histone mRNA metabolic process | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0071565 | nBAF complex | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 3 | 11 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.99e-02 | 1.00e+00 | 2.337 | 3 | 23 | 341 |
GO:0006337 | nucleosome disassembly | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 13 |
GO:0016514 | SWI/SNF complex | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 3 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 14 |
GO:0043393 | regulation of protein binding | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 15 |
GO:0016922 | ligand-dependent nuclear receptor binding | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 15 |
GO:0070932 | histone H3 deacetylation | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 2 | 16 |
GO:0031047 | gene silencing by RNA | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 2 | 18 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 19 |
GO:0008380 | RNA splicing | 3.27e-02 | 1.00e+00 | 2.800 | 2 | 21 | 165 |
GO:0043044 | ATP-dependent chromatin remodeling | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 3 | 20 |
GO:0006913 | nucleocytoplasmic transport | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 20 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 22 |
GO:0004842 | ubiquitin-protein transferase activity | 3.79e-02 | 1.00e+00 | 2.682 | 2 | 17 | 179 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 6 | 24 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.22e-02 | 1.00e+00 | 1.918 | 3 | 29 | 456 |
GO:0030901 | midbrain development | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 1 | 25 |
GO:0031492 | nucleosomal DNA binding | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 3 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 3 | 25 |
GO:0009267 | cellular response to starvation | 4.43e-02 | 1.00e+00 | 4.466 | 1 | 1 | 26 |
GO:0005057 | receptor signaling protein activity | 4.43e-02 | 1.00e+00 | 4.466 | 1 | 2 | 26 |
GO:0044822 | poly(A) RNA binding | 4.48e-02 | 1.00e+00 | 1.524 | 4 | 45 | 799 |
GO:0050885 | neuromuscular process controlling balance | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 28 |
GO:0000228 | nuclear chromosome | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 4 | 29 |
GO:0042752 | regulation of circadian rhythm | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 29 |
GO:0007254 | JNK cascade | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 5 | 35 |
GO:0031124 | mRNA 3'-end processing | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 4 | 35 |
GO:0044297 | cell body | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 5 | 35 |
GO:0030900 | forebrain development | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 36 |
GO:0003743 | translation initiation factor activity | 6.25e-02 | 1.00e+00 | 3.956 | 1 | 8 | 37 |
GO:0010467 | gene expression | 6.27e-02 | 1.00e+00 | 1.688 | 3 | 49 | 535 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 5 | 38 |
GO:0048511 | rhythmic process | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 5 | 38 |
GO:0003684 | damaged DNA binding | 6.91e-02 | 1.00e+00 | 3.808 | 1 | 1 | 41 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 1 | 42 |
GO:0017053 | transcriptional repressor complex | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 2 | 42 |
GO:0001047 | core promoter binding | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 4 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 5 | 42 |
GO:0006406 | mRNA export from nucleus | 7.40e-02 | 1.00e+00 | 3.707 | 1 | 7 | 44 |
GO:0005634 | nucleus | 7.41e-02 | 1.00e+00 | 0.671 | 9 | 158 | 3246 |
GO:0001570 | vasculogenesis | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 2 | 45 |
GO:0000502 | proteasome complex | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 3 | 47 |
GO:0008203 | cholesterol metabolic process | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 1 | 47 |
GO:0001558 | regulation of cell growth | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 2 | 49 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 4 | 49 |
GO:0006310 | DNA recombination | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 8.68e-02 | 1.00e+00 | 3.466 | 1 | 8 | 52 |
GO:0006338 | chromatin remodeling | 9.16e-02 | 1.00e+00 | 3.385 | 1 | 7 | 55 |
GO:0008584 | male gonad development | 9.48e-02 | 1.00e+00 | 3.333 | 1 | 1 | 57 |
GO:0003697 | single-stranded DNA binding | 9.48e-02 | 1.00e+00 | 3.333 | 1 | 4 | 57 |
GO:0000785 | chromatin | 9.80e-02 | 1.00e+00 | 3.283 | 1 | 6 | 59 |
GO:0006464 | cellular protein modification process | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 4 | 61 |
GO:0005739 | mitochondrion | 1.03e-01 | 1.00e+00 | 1.387 | 3 | 32 | 659 |
GO:0030018 | Z disc | 1.06e-01 | 1.00e+00 | 3.166 | 1 | 3 | 64 |
GO:0047485 | protein N-terminus binding | 1.07e-01 | 1.00e+00 | 3.144 | 1 | 6 | 65 |
GO:0030308 | negative regulation of cell growth | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 5 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.17e-01 | 1.00e+00 | 3.016 | 1 | 2 | 71 |
GO:0001889 | liver development | 1.17e-01 | 1.00e+00 | 3.016 | 1 | 4 | 71 |
GO:0016363 | nuclear matrix | 1.20e-01 | 1.00e+00 | 2.976 | 1 | 10 | 73 |
GO:0051726 | regulation of cell cycle | 1.20e-01 | 1.00e+00 | 2.976 | 1 | 3 | 73 |
GO:0001649 | osteoblast differentiation | 1.21e-01 | 1.00e+00 | 2.956 | 1 | 5 | 74 |
GO:0044267 | cellular protein metabolic process | 1.24e-01 | 1.00e+00 | 1.707 | 2 | 14 | 352 |
GO:0042127 | regulation of cell proliferation | 1.31e-01 | 1.00e+00 | 2.844 | 1 | 4 | 80 |
GO:0030529 | ribonucleoprotein complex | 1.34e-01 | 1.00e+00 | 2.808 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 5 | 84 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.38e-01 | 1.00e+00 | 1.608 | 2 | 21 | 377 |
GO:0005737 | cytoplasm | 1.47e-01 | 1.00e+00 | 0.611 | 7 | 127 | 2633 |
GO:0008201 | heparin binding | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 4 | 91 |
GO:0000209 | protein polyubiquitination | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.52e-01 | 1.00e+00 | 2.611 | 1 | 9 | 94 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 7 | 97 |
GO:0006457 | protein folding | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 5 | 97 |
GO:0009615 | response to virus | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 3 | 97 |
GO:0006413 | translational initiation | 1.59e-01 | 1.00e+00 | 2.537 | 1 | 6 | 99 |
GO:0010628 | positive regulation of gene expression | 1.69e-01 | 1.00e+00 | 2.438 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 9 | 109 |
GO:0006397 | mRNA processing | 1.75e-01 | 1.00e+00 | 2.385 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 1.78e-01 | 1.00e+00 | 2.359 | 1 | 4 | 112 |
GO:0000398 | mRNA splicing, via spliceosome | 2.01e-01 | 1.00e+00 | 2.166 | 1 | 15 | 128 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 2.21e-01 | 1.00e+00 | 2.016 | 1 | 7 | 142 |
GO:0016874 | ligase activity | 2.26e-01 | 1.00e+00 | 1.976 | 1 | 11 | 146 |
GO:0007399 | nervous system development | 2.34e-01 | 1.00e+00 | 1.918 | 1 | 4 | 152 |
GO:0001701 | in utero embryonic development | 2.37e-01 | 1.00e+00 | 1.899 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.49e-01 | 1.00e+00 | 1.817 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 2.58e-01 | 1.00e+00 | 1.757 | 1 | 10 | 170 |
GO:0000166 | nucleotide binding | 2.66e-01 | 1.00e+00 | 1.707 | 1 | 13 | 176 |
GO:0006412 | translation | 2.69e-01 | 1.00e+00 | 1.690 | 1 | 12 | 178 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.69e-01 | 1.00e+00 | 0.981 | 2 | 22 | 582 |
GO:0008152 | metabolic process | 2.74e-01 | 1.00e+00 | 1.658 | 1 | 6 | 182 |
GO:0003713 | transcription coactivator activity | 2.76e-01 | 1.00e+00 | 1.642 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 2.82e-01 | 1.00e+00 | 1.611 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 2.82e-01 | 1.00e+00 | 1.611 | 1 | 10 | 188 |
GO:0005743 | mitochondrial inner membrane | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 9 | 197 |
GO:0007165 | signal transduction | 2.93e-01 | 1.00e+00 | 0.894 | 2 | 24 | 618 |
GO:0035556 | intracellular signal transduction | 2.96e-01 | 1.00e+00 | 1.529 | 1 | 5 | 199 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.01e-01 | 1.00e+00 | 1.501 | 1 | 14 | 203 |
GO:0043234 | protein complex | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 7 | 210 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.10e-01 | 1.00e+00 | 0.835 | 2 | 29 | 644 |
GO:0005813 | centrosome | 3.18e-01 | 1.00e+00 | 1.404 | 1 | 10 | 217 |
GO:0030198 | extracellular matrix organization | 3.23e-01 | 1.00e+00 | 1.378 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.32e-01 | 1.00e+00 | 1.327 | 1 | 4 | 229 |
GO:0019901 | protein kinase binding | 3.36e-01 | 1.00e+00 | 1.308 | 1 | 8 | 232 |
GO:0008283 | cell proliferation | 3.44e-01 | 1.00e+00 | 1.265 | 1 | 8 | 239 |
GO:0006355 | regulation of transcription, DNA-templated | 3.57e-01 | 1.00e+00 | 0.684 | 2 | 31 | 715 |
GO:0003682 | chromatin binding | 3.59e-01 | 1.00e+00 | 1.189 | 1 | 15 | 252 |
GO:0005829 | cytosol | 3.80e-01 | 1.00e+00 | 0.363 | 4 | 88 | 1787 |
GO:0043565 | sequence-specific DNA binding | 3.85e-01 | 1.00e+00 | 1.063 | 1 | 8 | 275 |
GO:0008285 | negative regulation of cell proliferation | 3.87e-01 | 1.00e+00 | 1.052 | 1 | 11 | 277 |
GO:0008284 | positive regulation of cell proliferation | 3.89e-01 | 1.00e+00 | 1.042 | 1 | 8 | 279 |
GO:0000278 | mitotic cell cycle | 4.27e-01 | 1.00e+00 | 0.871 | 1 | 28 | 314 |
GO:0048471 | perinuclear region of cytoplasm | 4.57e-01 | 1.00e+00 | 0.740 | 1 | 11 | 344 |
GO:0042802 | identical protein binding | 4.66e-01 | 1.00e+00 | 0.698 | 1 | 15 | 354 |
GO:0005524 | ATP binding | 4.69e-01 | 1.00e+00 | 0.365 | 2 | 37 | 892 |
GO:0046872 | metal ion binding | 4.94e-01 | 1.00e+00 | 0.299 | 2 | 24 | 934 |
GO:0003677 | DNA binding | 5.01e-01 | 1.00e+00 | 0.279 | 2 | 52 | 947 |
GO:0006915 | apoptotic process | 5.19e-01 | 1.00e+00 | 0.483 | 1 | 15 | 411 |
GO:0016032 | viral process | 5.34e-01 | 1.00e+00 | 0.424 | 1 | 30 | 428 |
GO:0070062 | extracellular vesicular exosome | 5.63e-01 | 1.00e+00 | 0.071 | 3 | 51 | 1641 |
GO:0006351 | transcription, DNA-templated | 5.73e-01 | 1.00e+00 | 0.094 | 2 | 47 | 1076 |
GO:0016020 | membrane | 6.40e-01 | 1.00e+00 | -0.071 | 2 | 56 | 1207 |
GO:0005887 | integral component of plasma membrane | 6.44e-01 | 1.00e+00 | -0.001 | 1 | 8 | 575 |
GO:0008270 | zinc ion binding | 7.32e-01 | 1.00e+00 | -0.340 | 1 | 39 | 727 |
GO:0005886 | plasma membrane | 8.45e-01 | 1.00e+00 | -0.635 | 2 | 46 | 1784 |
GO:0016021 | integral component of membrane | 9.44e-01 | 1.00e+00 | -1.410 | 1 | 19 | 1526 |